Finance: 
Product: 
Team: 
Marketing: 
Summary
| Website: | https://luvenmed.io |
| Type: | Pre-ICO |
| Category: | Health Care |
| Verified team: | No |
| Whitelist of investors: | No |
| KYC of investors: | No |
| Goal of funding (Soft cap): | (not set) |
| Goal of funding (Hard cap): | (not set) |
| Tokens for sale: | 30,000,000 LVN |
| Token price: | 1 LVN = 0.003448 ETH |
| Minimum purchase: | (not set) |
| Maximum purchase: | (not set) |
| Have escrow agent: | No |
| Have working prototype: | Yes |
| White paper: | Open |
| Currencies: | ETH and BTC |
| Platform: | Ethereum |
| Exchange markets: | |
| Location: | Ukraine |
| Links: |
Description
Unique cancer diagnostic technology designed to save millions of lives. The Luven technology allows to detect the disease in its early stages, thus, preventing its progression in thousands of patients.
Funding Information
Cercentage of completion 100%
Distribution
| CLINICAL TRIALS | 50.00% |
| MARKETING | 25.00% |
| SOFTWARE | 15.00% |
| LEGAL COMPONENT | 10.00% |
| TEAM REMUNERATION | 7.00% |
| BOUNTY CAMPAIGN | 3.00% |
Bonuses and discounts
| 1-st Day: | 30% |
| 1-st week: | 25% |
| 2nd week: | 20% |
| 3d week: | 15% |
| 1st week of ICO: | 10% |
| >= 5,000 ETH: | 5% |
| >= 3,000 ETH: | 4% |
| >= 1,000 ETH: | 3% |
| >= 100 ETH: | 2% |
| >= 3 ETH: | 1% |
Team
Alexander Danilchenko
CEO, Team Leadership
Grigory Evglevskiy
CTO, Developer, Lead Software engineer
Aleksander Shchukin
Nuclear physicist
Nikolay Shchukin
Biomedical Engineer
Galina Shchukina
Geneticist & Cytologist
Alexander Kamensky
Principal Software Engineer
Yana Ivchenko
PR Manager
Lina Lisitsa
SMO/SMM Manager
Video
Latest tweets
Statistics
Similar ICO
TRUFIELD Pre-ICO
RxSmartCoffee ICO
TeamMate Pre-ICO
WELL ICO
flyCARE ICO
ARNA Panacea Pre-ICO
Cardium Pre-ICO
Gene Blockchain Token Pre-ICOLatest Articles
Latest ICO's
 | Bluetherium Ended on Jun 12, 2019 | R6.67 |
 | DENcoin Ended on Jun 30, 2019 | R7.08 |
 | Storecoin Ended on Jun 30, 2019 | R5.38 |
 | Ally Network Ended on Apr 7, 2019 | R7.50 |
 | Weriz Ended on May 31, 2019 | R6.25 |